These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Serum levels of coenzyme Q in patients with Lewy body disease. Molina JA; de Bustos F; Ortiz S; Del Ser T; Seijo M; Benito-Léon J; Oliva JM; Pérez S; Manzanares J J Neural Transm (Vienna); 2002 Sep; 109(9):1195-201. PubMed ID: 12203046 [TBL] [Abstract][Full Text] [Related]
6. Serum cholesterol levels and the risk of Parkinson's disease. de Lau LM; Koudstaal PJ; Hofman A; Breteler MM Am J Epidemiol; 2006 Nov; 164(10):998-1002. PubMed ID: 16905642 [TBL] [Abstract][Full Text] [Related]
7. Pilot trial of high dosages of coenzyme Q10 in patients with Parkinson's disease. Shults CW; Flint Beal M; Song D; Fontaine D Exp Neurol; 2004 Aug; 188(2):491-4. PubMed ID: 15246848 [TBL] [Abstract][Full Text] [Related]
8. Randomized, double-blind, placebo-controlled pilot trial of reduced coenzyme Q10 for Parkinson's disease. Yoritaka A; Kawajiri S; Yamamoto Y; Nakahara T; Ando M; Hashimoto K; Nagase M; Saito Y; Hattori N Parkinsonism Relat Disord; 2015 Aug; 21(8):911-6. PubMed ID: 26054881 [TBL] [Abstract][Full Text] [Related]
9. Coenzyme Q10 levels correlate with the activities of complexes I and II/III in mitochondria from parkinsonian and nonparkinsonian subjects. Shults CW; Haas RH; Passov D; Beal MF Ann Neurol; 1997 Aug; 42(2):261-4. PubMed ID: 9266740 [TBL] [Abstract][Full Text] [Related]
10. A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit. ; Beal MF; Oakes D; Shoulson I; Henchcliffe C; Galpern WR; Haas R; Juncos JL; Nutt JG; Voss TS; Ravina B; Shults CM; Helles K; Snively V; Lew MF; Griebner B; Watts A; Gao S; Pourcher E; Bond L; Kompoliti K; Agarwal P; Sia C; Jog M; Cole L; Sultana M; Kurlan R; Richard I; Deeley C; Waters CH; Figueroa A; Arkun A; Brodsky M; Ondo WG; Hunter CB; Jimenez-Shahed J; Palao A; Miyasaki JM; So J; Tetrud J; Reys L; Smith K; Singer C; Blenke A; Russell DS; Cotto C; Friedman JH; Lannon M; Zhang L; Drasby E; Kumar R; Subramanian T; Ford DS; Grimes DA; Cote D; Conway J; Siderowf AD; Evatt ML; Sommerfeld B; Lieberman AN; Okun MS; Rodriguez RL; Merritt S; Swartz CL; Martin WR; King P; Stover N; Guthrie S; Watts RL; Ahmed A; Fernandez HH; Winters A; Mari Z; Dawson TM; Dunlop B; Feigin AS; Shannon B; Nirenberg MJ; Ogg M; Ellias SA; Thomas CA; Frei K; Bodis-Wollner I; Glazman S; Mayer T; Hauser RA; Pahwa R; Langhammer A; Ranawaya R; Derwent L; Sethi KD; Farrow B; Prakash R; Litvan I; Robinson A; Sahay A; Gartner M; Hinson VK; Markind S; Pelikan M; Perlmutter JS; Hartlein J; Molho E; Evans S; Adler CH; Duffy A; Lind M; Elmer L; Davis K; Spears J; Wilson S; Leehey MA; Hermanowicz N; Niswonger S; Shill HA; Obradov S; Rajput A; Cowper M; Lessig S; Song D; Fontaine D; Zadikoff C; Williams K; Blindauer KA; Bergholte J; Propsom CS; Stacy MA; Field J; Mihaila D; Chilton M; Uc EY; Sieren J; Simon DK; Kraics L; Silver A; Boyd JT; Hamill RW; Ingvoldstad C; Young J; Thomas K; Kostyk SK; Wojcieszek J; Pfeiffer RF; Panisset M; Beland M; Reich SG; Cines M; Zappala N; Rivest J; Zweig R; Lumina LP; Hilliard CL; Grill S; Kellermann M; Tuite P; Rolandelli S; Kang UJ; Young J; Rao J; Cook MM; Severt L; Boyar K JAMA Neurol; 2014 May; 71(5):543-52. PubMed ID: 24664227 [TBL] [Abstract][Full Text] [Related]
11. Altered redox state of platelet coenzyme Q10 in Parkinson's disease. Götz ME; Gerstner A; Harth R; Dirr A; Janetzky B; Kuhn W; Riederer P; Gerlach M J Neural Transm (Vienna); 2000; 107(1):41-8. PubMed ID: 10809402 [TBL] [Abstract][Full Text] [Related]
12. Effects of coenzyme Q10 in early Parkinson disease: evidence of slowing of the functional decline. Shults CW; Oakes D; Kieburtz K; Beal MF; Haas R; Plumb S; Juncos JL; Nutt J; Shoulson I; Carter J; Kompoliti K; Perlmutter JS; Reich S; Stern M; Watts RL; Kurlan R; Molho E; Harrison M; Lew M; Arch Neurol; 2002 Oct; 59(10):1541-50. PubMed ID: 12374491 [TBL] [Abstract][Full Text] [Related]
13. A randomized clinical trial of coenzyme Q10 and GPI-1485 in early Parkinson disease. NINDS NET-PD Investigators Neurology; 2007 Jan; 68(1):20-8. PubMed ID: 17200487 [TBL] [Abstract][Full Text] [Related]
14. Plasma ubiquinone status and response to six-month supplementation combined with multivitamins in healthy elderly women--results of a randomized, double-blind, placebo-controlled study. Wolters M; Hahn A Int J Vitam Nutr Res; 2003 May; 73(3):207-14. PubMed ID: 12847998 [TBL] [Abstract][Full Text] [Related]
16. Serum levels of coenzyme Q10 in patients with multiple sclerosis. de Bustos F; Jiménez-Jiménez FJ; Molina JA; Gómez-Escalonilla C; de Andrés C; del Hoyo P; Zurdo M; Tallón-Barranco A; Berbel A; Porta-Etessam J; Parrilla G; Arenas J Acta Neurol Scand; 2000 Mar; 101(3):209-11. PubMed ID: 10705945 [TBL] [Abstract][Full Text] [Related]
17. Coenzyme Q10 supplementation reduces oxidative stress and increases antioxidant enzyme activity in patients with coronary artery disease. Lee BJ; Huang YC; Chen SJ; Lin PT Nutrition; 2012 Mar; 28(3):250-5. PubMed ID: 21996047 [TBL] [Abstract][Full Text] [Related]
18. Serum coenzyme Q10 and risk of disabling dementia: the Circulatory Risk in Communities Study (CIRCS). Yamagishi K; Ikeda A; Moriyama Y; Chei CL; Noda H; Umesawa M; Cui R; Nagao M; Kitamura A; Yamamoto Y; Asada T; Iso H; Atherosclerosis; 2014 Dec; 237(2):400-3. PubMed ID: 25463064 [TBL] [Abstract][Full Text] [Related]
19. Oxidative stress in skin fibroblasts cultures from patients with Parkinson's disease. del Hoyo P; García-Redondo A; de Bustos F; Molina JA; Sayed Y; Alonso-Navarro H; Caballero L; Arenas J; Agúndez JA; Jiménez-Jiménez FJ BMC Neurol; 2010 Oct; 10():95. PubMed ID: 20958999 [TBL] [Abstract][Full Text] [Related]
20. A significant correlation between the plasma levels of coenzyme Q10 and vitamin B-6 and a reduced risk of coronary artery disease. Lee BJ; Yen CH; Hsu HC; Lin JY; Hsia S; Lin PT Nutr Res; 2012 Oct; 32(10):751-6. PubMed ID: 23146771 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]